Literature DB >> 234470

Evidence for involvement of protein kinase in the activation by adenosine 3':5'-monophosphate of brain tyrosine 3-monooxygenase.

V H Morgenroth, L R Hegstrand, R H Roth, P Greengard.   

Abstract

Addition of adenosine 3':5'-monophosphate (cAMP) to high speed supernatant preparations obtained from rat brain caused a 3- to 4-fold increase in tyrosine 3-monooxygenase (tyrosine hydroxylase) activity. The tyrosine 3-monooxygenase remained in an activated state upon removal of the cAMP by passing the enzyme through a Sephadex G-25 column. Substances which inhibit cAMP-dependent protein kinase, namely, EDTA, ADP, and adenosine, and protein kinase modulator, each antagonized the activation of tyrosine 3-monooxygenase produced by cAMP. Furthermore, addition of partially purified brain cAMP-dependent protein kinase caused a several-fold increase in tyrosin 3-monooxygenase activity. The activation of tyrosine 3-monooxygenase by added cAMP and protein kinase required the presence of ATP and Mg-2+. These data suggests that the cAMP activation of tyrosine 3-monooxygenase may be mediated by a cAMP-dependent protein kinase.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 234470

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease.

Authors:  Gurdeep Marwarha; Turk Rhen; Trevor Schommer; Othman Ghribi
Journal:  J Neurochem       Date:  2011-10-24       Impact factor: 5.372

2.  Tyrosine hydroxylase: allosteric activation induced by stimulation of central noradrenergic neurons.

Authors:  R H Roth; V H Morgenroth; P M Salzman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

3.  Tyrosine hydroxylase activation and transmitter release from central noradrenergic neurons by electrical field stimulation.

Authors:  G Bustos; R H Roth; V H Morgenroth; J L Hancke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978 Jan-Feb       Impact factor: 3.000

4.  Activation of rat pheochromocytoma tyrosine hydroxylase by a cyclic AMP-dependent protein kinase in a cell-free system.

Authors:  G S Drummond; E Symchowicz; M Goldstein; L Shenkman
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

5.  Direct phosphorylation of brain tyrosine hydroxylase by cyclic AMP-dependent protein kinase: mechanism of enzyme activation.

Authors:  T H Joh; D H Park; D J Reis
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

6.  Control of adenylate cyclase from secretory vesicle membranes by beta-adrenergic agents and nerve growth factor.

Authors:  O Nikodijevic; B Nikodijevic; O Zinder; M Y Yu; G Guroff; H B Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

7.  The regulation of striatal tyrosine hydroxylase. Effects of gamma hydroxybutric acid and healperidol.

Authors:  B Zivkovic; A Guidotti; E Costa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

8.  A dual role for the cAMP-dependent protein kinase in tyrosine hydroxylase gene expression.

Authors:  K S Kim; D H Park; T C Wessel; B Song; J A Wagner; T H Joh
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Identification of tyrosine hydroxylase as a physiological substrate for Cdk5.

Authors:  Janice W Kansy; S Colette Daubner; Akinori Nishi; Naoki Sotogaku; Michael D Lloyd; Chan Nguyen; Lin Lu; John W Haycock; Bruce T Hope; Paul F Fitzpatrick; James A Bibb
Journal:  J Neurochem       Date:  2004-10       Impact factor: 5.372

10.  Roles of db-cAMP, IBMX and RA in aspects of neural differentiation of cord blood derived mesenchymal-like stem cells.

Authors:  Murni Tio; Kian Hwa Tan; Wendy Lee; Ting Ting Wang; Gerald Udolph
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.